Cancer remains a formidable challenge in healthcare with an urgent need to continuously improve diagnostic and therapeutic strategies. With a background in human biology and oncology, I am intrigued by how tumours and associated cells of the tumour microenvironment in aggressive solid malignancies learn to adapt and hijack normal physiological processes in hosts to support their maintenance and treatment resistance. Tumours undergo frequent metabolic alterations that support disease progression and are indicative of changing cellular states in response to pharmacological interventions. I am enthusiastic to further explore this topic with my PhD in Radiology at the University of Cambridge in collaboration with AstraZeneca, where I will have the opportunity to make use of novel, non-invasive hyperpolarised MRI imaging tools and advanced tissue analysis methods to probe changes in tumour metabolism in real time. With the aim of identifying targetable vulnerabilities and characterising drug-target interactions in cancer, I hope that our research brings us a step closer towards improving our understanding of classifying tumour heterogeneity, monitoring early response, and optimising treatment plans in the clinic.
Ludwig-Maximilians-Universitat Munchen MSc in Human Biology 2026
Amity University Kolkata BSc in Biotechnology 2022